12.11.2018 Issue 431

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

HEOR & RWE Marketplace Streamlines Sourcing, Procurement

Wednesday, December 5

HealthEconomics.Com and Scientist.com’s HEOR & RWE Markeplace is in full swing, bolstering the sourcing and procurement process for researchers and suppliers of HEOR, RWE and market access services.

FDA to Use 3-Step Approach in RWE Initiative

FDA Creating Roadmap for RWE Integration

Deloitte: Value-Based Models Slow to Gain Momentum

ISPOR Seeks Abstract, Proposal Reviewers for New Orleans Meeting

Report: Consumer Shouldering More Health Costs

NPC Backs FDA’s RWE Framework, Says It’s a Step in Right Direction

New CVS Offering to Compete with Amazon

Forbes Summit Spurs Robust Talks on Drug Prices, Innovation in Pharma

Researcher - HEOR

Executive Director, Health Technology Assessment (HTA) Statistics (U.S.)

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Associate Director, Health Economics & Outcomes Research

Industry Spotlight

Conferences Webinars
14th Annual Trade and Channel Strategies
    December 11-12, Philadelphia, Pennsylvania

Specialty Product Data Strategies
    December 12, Philadelphia, Pennsylvania

ESMO Immuno-Oncology Congress 2018
    December 13-16, Geneva, Switzerland

Health Economics for Non-Health-Economists
    December 13-14, Brussels, Belgium

Reimbursement and Contracting
    January 23-24, Philadelphia, Pennsylvania

Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA’s Expanded Access
    December 11

Intelligent Approaches to Transform Value and Access
    December 12

Managing Challenging Long-term Services and Supports Patients to Improve Care and Reduce Costs
    December 13

Identifying Medical Conditions in Administrative Claims Data: Validation and Machine Learning
    January 8

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven
Share this newsletter on social media:

Email Twitter Facebook LinkedIn